Combining gabapentin with alcohol can cause severe central nervous system depression, including dangerous levels of sedation, respiratory depression, and loss of consciousness. Both substances enhance inhibitory signaling in the brain, and their combined effect can be unpredictable and potentially fatal.
How This Interaction Works (Mechanism)
Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release. Alcohol enhances GABA-A receptor activity and suppresses NMDA receptor function. Together, they produce additive CNS depression by simultaneously reducing excitatory signaling through multiple pathways. This can suppress the brainstem respiratory centers, leading to dangerously slow or shallow breathing.
Source: FDA Boxed Warning Update for Gabapentinoids, 2023
Avoid alcohol entirely while taking gabapentin. If you have a history of alcohol use disorder, inform your doctor before starting gabapentin. Watch for signs of excessive sedation: extreme drowsiness, slurred speech, difficulty breathing, or inability to stay awake. Call 911 immediately if someone taking gabapentin and alcohol becomes difficult to wake or shows signs of respiratory distress.
Check More Drug Interactions
Use our free interaction checker to search thousands of drug, supplement, and food combinations.
Open Interaction CheckerKeep a multi-drug routine straight
As an Amazon Associate I earn from qualifying purchases.
Sources and standards behind this page
What a drug interaction does, and how strongly it is supported, is documented in public labeling and federal safety references rather than in any one summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- DailyMed carries the current FDA labeling for every marketed drug product, including the warnings and drug interaction sections.
- Drugs@FDA is the federal database of approved drug products and their approval documents.
- FDA: Drug interactions, what you should know explains how drug-drug, drug-food and drug-condition interactions are described on labels.
- FDA Drug Safety Communications publishes the agency's safety alerts and label changes as they are issued.
- FDA MedWatch is the program for reporting and reviewing adverse events, including suspected interactions.
- openFDA provides public access to FDA labeling and adverse event data.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medicine is and how it is taken.
- NIAAA: Harmful interactions documents which medicines interact with alcohol and how.
- NCCIH: Herb-drug interactions summarises the evidence on interactions between herbal products and medicines.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how this interaction works and where it is documented. It is not medical advice: a prescriber or pharmacist decides what applies to a particular patient and medication.
Frequently Asked Questions
Gabapentin and Alcohol have a severe interaction and should generally not be taken together without close medical supervision. The combination can cause serious, potentially life-threatening side effects. Contact your doctor immediately if you are currently taking both medications.
Combining gabapentin with alcohol can cause severe central nervous system depression, including dangerous levels of sedation, respiratory depression, and loss of consciousness. Both substances enhance inhibitory signaling in the brain, and their combined effect can be unpredictable and potentially fatal.
Yes. Anytime you are taking multiple medications, supplements, or substances, you should inform your doctor and pharmacist. They can evaluate your specific risk factors (age, kidney function, other medications, medical conditions) and determine whether the Gabapentin and Alcohol combination is safe for you, or whether adjustments are needed.
Related Resources
Get Drug Safety Alerts
Leave your email for updates on FDA warnings, new drug interactions, and patient safety information. We have not started sending yet, and we will only email when we do.